DROTOKIBART
UNII FA6H9P65L6

Substance Identification & Data

This profile provides standardized clinical and technical data for Drotokibart, uniquely identified by the FDA Unique Ingredient Identifier (UNII) FA6H9P65L6.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2925270-26-2 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
FA6H9P65L6
CAS Registry Number
2925270-26-2
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
DROTOKIBART
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
INN ID
13214
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Drotokibart. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

DROTOKIBART
DROTOKIBART [INN]
H-GAMMA4 HEAVY CHAIN HUMANIZED (1-445) (VH (HOMO SAPIENS IGHV3-48*01 (88.8%) -(IGHD) -IGHJ4*01 (93.3%), CDR-IMGT (8.8.11) (26-33.51-58.97-107)) (1-118) -HOMO SAPIENS IGHG4*01, NG4M(A) CH2 L92, G4V5 H P10 (CH1 (119-216), HINGE 1-12 S10>P (226) (217-228), CH2 L92 (307) (229-338), CH3 (339-443), CHS (444-445)) (119-445)), (132-215')-DISULFIDE WITH L-KAPPA LIGHT CHAIN HUMANIZED (1'-215') (VKAPPA (HOMO SAPIENS IGKV3D-11*02 (88.9%) -IGKJ4*01 (100%), CDR-IMGT (5.3.11) (27'-31'.49'-51'.88'-98')) (1'-108') -HOMO SAPIENS IGKC*01 (100%) KM3 A45.1, V101 (C-KAPPA A45.1 (154'), V101 (192')) (109'-215')); DIMER (224-224'':227-227'')-BISDISULFIDE, PRODUCED IN CHINESE HAMSTER OVARY (CHO) CELLS, CELL LINE CHO-K1SV LACKING THE GLUTAMINE SYNTHETASE (GS-KO) GENE, GLYCOFORM ALFA
IMMUNOGLOBULIN G4 (226-PROLINE), ANTI-(HUMAN INTERLEUKIN-4 RECEPTOR SUBUNIT .ALPHA.) (HUMAN-MUS MUSCULUS MONOCLONAL ER006-01 .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL ER006-01 .KAPPA.-CHAIN, DIMER
IMMUNOGLOBULIN G4-KAPPA, ANTI-(HOMO SAPIENS IL4R (INTERLEUKIN 4 RECEPTOR, IL4RA, IL-4RA, INTERLEUKIN 13 RECEPTOR, CD124)), HUMANIZED MONOCLONAL ANTIBODY